# US 2025/0060287 A1 · Method of Acquiring Liquid Biological Samples from an Extracorporeal Circuit for an Extracorporeal Blood Purification Treatment and Related Apparatus And System

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0060287 A1
- Document ID: US20250060287A1
- Status: Published application
- Kind: A1
- Application number: 18/723,818
- Filed: 2022-12-15
- Published: 2025-02-20
- Earliest claimed: 2021-12-24
- Assignees: Politecnico Di Torino; Universita' Degli Studi Di Firenze; Azienda Ospedaliero Universitaria Di Careggi; Azienda Ospedaliera Universitaria Meyer Irccs
- Applicants: Politecnico Di Torino; Università Degli Studi Di Firenze; Azienda Ospedaliero Universitaria Di Careggi; Azienda Ospedaliera Universitaria Meyer Irccs
- Inventors: Valentina Cauda; Andrea Ancona; Gianluca Villa; Stefano Romagnoli; Zaccaria Ricci
- Web page: https://patentgrep.com/patent/US20250060287A1

## CPC

- A61M 1/1609: {after use, i.e. downstream of dialyser}
- G01N 1/20: for flowing or falling materials ({G01N1/2035} G01N1/12, G01N1/14 take precedence)
- A61B 5/14546: {for measuring analytes not otherwise provided for, e.g. ions, cytochromes}
- A61B 5/6866: {Extracorporeal blood circuits, e.g. dialysis circuits}
- A61M 1/1619: {Sampled collection of used dialysate, i.e. obviating the need for recovery of whole dialysate quantity for post-dialysis analysis}
- A61M 1/3413: {Diafiltration}
- A61M 1/361: {before treatment}
- A61M 1/3612: {after treatment}
- G01N 1/14: Suction devices, e.g. pumps; Ejector devices
- G01N 33/491: {by separating the blood components (G01N15/05 takes precedence)}
- A61B 2562/0219: Inertial sensors, e.g. accelerometers, gyroscopes, tilt switches
- A61B 2562/0261: Strain gauges
- A61B 2562/0271: Thermal or temperature sensors
- G01N 2001/1031: {Sampling from special places}
- G01N 2001/1418: {Depression, aspiration}
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)

## Abstract

A method of acquiring liquid biological samples from an extracorporeal circuit for subjecting a patient to an extracorporeal blood purification treatment includes a sampling phase wherein: I) a first sampling port is in fluidic communication with a first collection chamber via a first hydraulic machine, the first sampling port being operatively connected to a first haematic line inputted to a haemodiafilter of the extracorporeal circuit; II) a second sampling port is in fluidic communication with a second collection chamber via a second hydraulic machine, the second sampling port being operatively connected to a second haematic line outputted from said haemodiafilter; III) a third sampling port is in fluidic communication with a third collection chamber via a third hydraulic machine, the third sampling port being operatively connected to an effluent line of the haemodiafilter, wherein each hydraulic machine fills a corresponding collection chamber with a corresponding biological sample.

## Claims

### Claim 1

A method of acquiring liquid biological samples from an extracorporeal circuit for subjecting a patient to an extracorporeal blood purification treatment, said method comprising a sampling phase wherein:
I) a first sampling port of said extracorporeal circuit is in fluidic communication with a first collection chamber via a first hydraulic machine, said first sampling port being operatively connected to a first haematic line inputted to a haemodiafilter of said extracorporeal circuit;
II) a second sampling port of said extracorporeal circuit is in fluidic communication with a second collection chamber via a second hydraulic machine, said second sampling port being operatively connected to a second haematic line outputted from said haemodiafilter;
III) a third sampling port of said extracorporeal circuit is in fluidic communication with a third collection chamber via a third hydraulic machine, said third sampling port being operatively connected to an effluent line of said haemodiafilter,
wherein said first hydraulic machine fills said first collection chamber with a first biological sample (A), said second hydraulic machine fills said second collection chamber with a second biological sample (B), and said third hydraulic machine fills said third collection chamber with a third biological sample (C), said first hydraulic machine, said second hydraulic machine and said third hydraulic machine being activated at the same time and with a flow rate value (P).

### Claim 2 (depends on 1)

The method according to claim 1, comprising:
an analysis phase, in which each one of said first biological sample (A), second biological sample (B) and third biological sample (C) are respectively subdivided into at least a first share (A1, B1, C1), a second share (A2, B2, C2) and a third share (A3, B3, C3), wherein said first share (A1, B1, C1) concerns a first solute having a first molecular mass value of 0 to 500 dalton, said second share (A2, B2, C2) concerns a second solute having a second molecular mass value of 501 to 5,000 dalton, and said third share (A3, B3, C3) concerns a third solute having a third molecular mass value of 5,001 to 100,000 dalton, and wherein concentration values of the first solute (C_A1, C_B1, C_C1), concentration values of the second solute (C_A2, C_B2, C_C2) and concentration values of the third solute (C_A3, C_B3, C_C3) are determined for each first share (A1, B1, C1), second share (A2,B2, C2) and third share (A3, B3, C3);
a first processing phase, in which a first mass balance error (Err1), a second mass balance error (Err2) and a third mass balance error (Err3) are determined on the basis of at least one of said concentration values of the first solute (C_A1, C_B1, C_C1), concentration values of the second solute (C_A2, C_B2, C_C2) and concentration values of the third solute (C_A3, C_B3, C_C3), said first mass balance error (Err1) concerning said first solute, said second mass balance error (Err2) concerning said second solute, and said third mass balance error (Err3) concerning said third solute;
a second processing phase, in which, for each one of said first solute, second solute and third solute, a clearance value (K1, K2, K3) and/or a sieving coefficient (H1,H2, H3) or an effluent saturation coefficient are determined when each one of said first mass balance error (Err1), second mass balance error (Err2) and third mass balance error (Err3) is comprised between-10% and +10%.

### Claim 3 (depends on 2)

The method according to claim 2, wherein each one of said concentration values of the first solute (C_A1, C_B1, C_C1), concentration values of the second solute (C_A2, C_B2, C_C2) and concentration values of the third solute (C_A3, C_B3,C_C3) are determined in accordance with one or more of the following methods: immunofluorimetric method, colorimetric method, UV method, electrochemical method, immunoturbidimetric method, potentiometric method.

### Claim 4

An apparatus for acquisition of liquid biological samples from an extracorporeal circuit for subjecting a patient to an extracorporeal blood purification treatment, said apparatus comprising a first hydraulic machine, a second hydraulic machine, a third hydraulic machine, and comprising:
I) a first collection chamber adapted to be in fluidic communication with a first sampling port of said extracorporeal circuit via said first hydraulic machine, said first sampling port being operatively connected to a first haematic line inputted to a haemodiafilter of said extracorporeal circuit;
II) a second collection chamber adapted to be in fluidic communication with a second sampling port of said extracorporeal circuit via said second hydraulic machine, said second sampling port being operatively connected to a second haematic line outputted from said haemodiafilter;
III) a third collection chamber adapted to be in fluidic communication with a third sampling port of said extracorporeal circuit via said third hydraulic machine, said third sampling port being operatively connected to an effluent line of said haemodiafilter,
said apparatus being characterized in that said first hydraulic machine is adapted to fill said first collection chamber with a first biological sample (A), said second hydraulic machine is adapted to fill said second collection chamber with a second biological sample (B), and said third hydraulic machine is adapted to fill said third collection chamber with a third biological sample (C), said first hydraulic machine, said second hydraulic machine and said third hydraulic machine being activable at the same time and with a flow rate value (P).

### Claim 5 (depends on 4)

The acquisition apparatus according to claim 4, wherein a storage unit comprises said first collection chamber, said second collection chamber and said third collection chamber, said storage unit being removable from said apparatus for acquisition of liquid biological samples.

### Claim 6

An analysis apparatus comprising actuator means, sensor means, memory means, and processing means adapted to:
receive a first collection chamber comprising a first biological sample (A), a second collection chamber comprising a second biological sample, and a third collection chamber comprising a third biological sample (C);
subdivide each one of said first biological sample (A), second biological sample (B) and third biological sample (C), respectively, into at least a first share (A1, B1, C1), a second share (A2, B2, C2) and a third share (A3, B3, C3), said first share (A1, B1, C1) concerning a first solute having a first molecular mass value of 0 to 500 dalton, said second share (A2, B2, C2) concerning a second solute having a second molecular mass value of 501 to 5,000 dalton, and said third share (A3, B3, C3) concerning a third solute having a third molecular mass value of 5,001 to 100,000 dalton;
determine, for each one of said first share (A1, B1, C1), second share (A2, B2,C2) and third share (A3, B3, C3), concentration values of the first solute (C_A1, C_B1,C_C1), concentration values of the second solute (C_A2, C_B2, C_C2) and concentration values of the third solute (C_A3, C_B3, C_C3);
determine a first mass balance error (Err1), a second mass balance error (Err2) and a third mass balance error (Err3) on the basis of at least one of said concentration values of the first solute (C_A1, C_B1, C_C1), concentration values of the second solute (C_A2,C_B2, C_C2) and concentration values of the third solute (C_A3, C_B3, C_C3), said first mass balance error (Err1) concerning said first solute, said second mass balance error (Err2) concerning said second solute, and said third mass balance error (Err3) concerning said third solute;
determine, for each one of said first solute, second solute and third solute, a clearance value (K1, K2, K3) and/or a sieving coefficient (H1, H2, H3) or an effluent saturation coefficient when each one of said first mass balance error (Err1), second mass balance error (Err2) and third mass balance error (Err3) is comprised between −10% and +10%.

### Claim 7 (depends on 6)

The analysis apparatus according to claim 6, wherein each one of said concentration values of the first solute (C_Al, C_B1, C_C1), concentration values of the second solute (C_A2, C_B2, C_C2) and concentration values of the third solute (C_A3, C_B3, C_C3) can be determined in accordance with one or more of the following methods: immunofluorimetric method, colorimetric method, UV method, electrochemical method, immunoturbidimetric method, and potentiometric method.

### Claim 8 (depends on 6)

The analysis apparatus according to claim 6, wherein a storage unit comprises said first collection chamber, said second collection chamber and said third collection chamber, said storage unit being removable from said analysis apparatus.

### Claim 9 (depends on 4)

A system for acquiring liquid biological samples from an extracorporeal circuit for subjecting a patient to an extracorporeal blood purification treatment, said system comprising a machine for subjecting a patient to an extracorporeal blood purification treatment, an apparatus for acquisition of liquid biological samples according to claim 4, and said extracorporeal circuit, operatively connected to one another.

### Claim 10

(canceled)
